Baxter International (NYSE:BAX – Free Report) had its target price lifted by JPMorgan Chase & Co. from $38.00 to $44.00 in a research report report published on Friday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical instruments supplier’s stock.
A number of other research firms have also commented on BAX. StockNews.com upgraded shares of Baxter International from a hold rating to a buy rating in a research report on Friday, January 19th. UBS Group dropped their target price on shares of Baxter International from $40.00 to $36.00 and set a neutral rating for the company in a research report on Tuesday, February 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Baxter International from $35.00 to $50.00 and gave the company a hold rating in a research report on Tuesday, October 24th. Finally, Morgan Stanley dropped their target price on shares of Baxter International from $45.00 to $39.00 and set an equal weight rating for the company in a research report on Monday, December 4th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus price target of $46.30.
Baxter International Price Performance
Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings data on Thursday, February 8th. The medical instruments supplier reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. Baxter International had a net margin of 17.77% and a return on equity of 19.49%. The company had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.81 billion. During the same period last year, the business earned $0.88 earnings per share. Baxter International’s revenue was up 3.5% compared to the same quarter last year. Equities analysts forecast that Baxter International will post 2.89 EPS for the current year.
Baxter International Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 1st will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 2.88%. Baxter International’s payout ratio is 22.22%.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. Headinvest LLC purchased a new position in shares of Baxter International in the third quarter worth $25,000. Indiana Trust & Investment Management CO purchased a new position in shares of Baxter International in the third quarter worth $27,000. RFP Financial Group LLC purchased a new position in Baxter International during the 2nd quarter valued at $36,000. Bruce G. Allen Investments LLC purchased a new position in Baxter International during the 4th quarter valued at $36,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in Baxter International during the 4th quarter valued at $37,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.
- Five stocks we like better than Baxter International
- What is the FTSE 100 index?
- 3 attractive stocks that insiders are buying
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- Insider Trades May Not Tell You What You Think
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.